医药行业分析
- (2024-12-11)
- (2024-12-11)
- (2024-12-11)
- (2024-12-11)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-10)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-09)
- (2024-12-08)
- (2024-12-08)
- (2024-12-07)
- (2024-12-07)
- (2024-12-06)
- (2024-12-06)
- (2024-12-06)
- (2024-12-06)
- (2024-12-06)
- (2024-12-06)
- (2024-12-06)
映恩生物和BioNTech在2024 ESMO Asia大会上公布了B7H3 ADC (DB-1311/BNT324)在晚期实体瘤患者中积极的研究数据
(2024-12-06)- (2024-12-06)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-05)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-04)
- (2024-12-03)
- (2024-12-03)